BDP9066
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-111424-50 mg |
| CAS # | 2226507-04-4 |
| Pricing | 50 mg, USD $950.0 |
| Biological Activity | BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β in house determinations, respectively. BDP9066 has therapeutic effect on skin cancer by reducing substrate phosphorylation. |
| MWt | 348.44 |
| Formula | C₂₀H₂₄N₆ |